PreveCeutical Medical PRVCF Stock
PreveCeutical Medical Price Chart
PreveCeutical Medical PRVCF Financial and Trading Overview
| PreveCeutical Medical stock price | 0.02 USD |
| Previous Close | 0.02 USD |
| Open | 0.02 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.02 - 0.02 USD |
| 52 Week Range | 0.01 - 0.03 USD |
| Volume | 175.15K USD |
| Avg. Volume | 39.5K USD |
| Market Cap | 10.87M USD |
| Beta (5Y Monthly) | 0.992303 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PRVCF Valuation Measures
| Enterprise Value | 14.33M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -12.379 |
Trading Information
PreveCeutical Medical Stock Price History
| Beta (5Y Monthly) | 0.992303 |
| 52-Week Change | 7.97% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.03 USD |
| 52 Week Low | 0.01 USD |
| 50-Day Moving Average | 0.02 USD |
| 200-Day Moving Average | 0.02 USD |
PRVCF Share Statistics
| Avg. Volume (3 month) | 39.5K USD |
| Avg. Daily Volume (10-Days) | 44.99K USD |
| Shares Outstanding | 535.3M |
| Float | 404.7M |
| Short Ratio | N/A |
| % Held by Insiders | 24.08% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 5:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -455.59% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -1157247 USD |
| Net Income Avi to Common (ttm) | -1261495 USD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 6.08K USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 3.47M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.008 |
| Book Value Per Share (mrq) | -0.009 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -75099 USD |
| Levered Free Cash Flow (ttm) | -157629 USD |
Profile of PreveCeutical Medical
| Country | United States |
| State | BC |
| City | Vancouver |
| Address | 885 Cambie Street |
| ZIP | V6B 0R6 |
| Phone | 604 416 7777 |
| Website | https://www.preveceutical.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; Non-Addictive Analgesic for pain management; BSV Peptide Program that targets cancer progression; and Dual Gene Therapy for type 2 diabetes and obesity. The company also develops a range of medicinal cannabis-based products. PreveCeutical Medical Inc. is headquartered in Vancouver, Canada.
Q&A For PreveCeutical Medical Stock
What is a current PRVCF stock price?
PreveCeutical Medical PRVCF stock price today per share is 0.02 USD.
How to purchase PreveCeutical Medical stock?
You can buy PRVCF shares on the OTC Markets OTCQB exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for PreveCeutical Medical?
The stock symbol or ticker of PreveCeutical Medical is PRVCF.
Which industry does the PreveCeutical Medical company belong to?
The PreveCeutical Medical industry is Biotechnology.
How many shares does PreveCeutical Medical have in circulation?
The max supply of PreveCeutical Medical shares is 542.21M.
What is PreveCeutical Medical Price to Earnings Ratio (PE Ratio)?
PreveCeutical Medical PE Ratio is now.
What was PreveCeutical Medical earnings per share over the trailing 12 months (TTM)?
PreveCeutical Medical EPS is 0 USD over the trailing 12 months.
Which sector does the PreveCeutical Medical company belong to?
The PreveCeutical Medical sector is Healthcare.